Saturday, October 3, 2026

USD/EUR Bearish Momentum: 0.81% Down In The Last 5 Sessions

ViaNews Editorial Team

October 12, 2023

USD/EUR Bearish Momentum: 0.81% Down In The Last 5 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.81% for the last 5 sessions. At 02:07 EST on Thursday, 12 October, USD/EUR (USDEUR) is $0.94.

USD/EUR's yearly highs and lows, it's 5.998% up from its 52-week low and 9.414% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.21%, a positive 0.04%, and a positive 0.31%, respectively.

USD/EUR's highest amplitude of average volatility was 0.21% (last week), 0.29% (last month), and 0.31% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Wednesday, 11 October, "Continued upward momentum could potentially propel EUR/USD to revisit the September 20 high of 1.0736, followed by the significant 200-day Simple Moving Average (SMA) at 1.0823. ", "As long as the EUR/USD remains below the 200-day SMA, the potential for sustained downward pressure persists."
  • Eur/usd trades with a mild positive bias on subdued USD demand, remains below 1.0600 mark. According to FXStreet on Tuesday, 10 October, "This points to a well-established short-term bearish trend and makes it prudent to wait for a strong follow-through buying before confirming that the EUR/USD pair has formed a near-term bottom around the 1.0450-1.0445 area, or the YTD trough set last week. ", "This, along with the US bond yields and the broader risk sentiment, will drive the USD demand and contribute to producing short-term trading opportunities around the EUR/USD pair in the absence of any relevant economic data."
  • According to FXStreet on Tuesday, 10 October, "The persistence of selling pressure on the EUR/USD could lead to a retesting of the 2023 low at 1.0448 seen on October 3and may even challenge the significant psychological level of 1.0400. ", "As long as the EUR/USD remains below the 200-day SMA, there is the possibility of continued downward pressure."
  • According to Business Insider on Tuesday, 10 October, "The EUR/USD pair, which is tracked by the Invesco CurrecyShares Euro Currency Trust (NYSE:FXE),was 0.4% higher to 1.0602."
  • Eur/usd finds respite as US yields dip as traders eye US and German inflation data. According to FXStreet on Tuesday, 10 October, "A light economic calendar on both sides of the Atlantic keeps the EUR/USD entertained on US Dollar dynamics and market mood. ", "The drop in German bond yields is capping the EUR/USD advance on the Eurozone front, while the European Central Bank (ECB) is expected to halt its tightening cycle, according to market participants."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com